Field Trip Health Ltd. to Participate in Upcoming Conferences in December 2021
December 01 2021 - 7:30AM
Field Trip Health Ltd. (TSX: FTRP, FTRP.WT, Nasdaq: FTRP) ("Field
Trip"), a global leader in the development and delivery of
psychedelic therapies, announced today that management will present
at H.C. Wainwright’s 2nd Annual Psychedelics Conference and
Stifel’s 2nd Annual Future of Healthcare Conference in December.
H.C. Wainwright’s 2nd Annual
Psychedelics ConferenceField Trip’s Co-Founder and CEO,
Joseph Del Moral, and Chief Scientific Officer, Dr. Nathan Bryson,
will present live at H.C. Wainwright’s 2nd Annual Psychedelics
Conference taking place on Monday, December 6th. A recording of
Field Trip’s presentation will be available on-demand from Monday,
December 6th at 7:00a.m. Eastern Time, through the following link:
https://journey.ct.events/view/c5617d9d-c81a-4cc7-b81d-754d93bb10be.
Stifel’s 2nd Annual Future of Healthcare
ConferenceField Trip’s Co-founder and Executive Chairman,
Ronan Levy, and Chief Scientific Officer, Dr. Nathan Bryson, will
present live at the Stifel Virtual Healthcare Conference on
Wednesday, December 8th at 12:30p.m. Eastern Time. To view the
presentation, please register via this link:
https://wsw.com/webcast/stifel62/register.aspx?conf=stifel62&page=ftrp&url=https://wsw.com/webcast/stifel62/ftrp/2112420.
Recordings of the presentations will be
accessible on Field Trip’s investor relations website via the above
links for 90 days.
Field Trip’s management team will be available
for one-on-one meetings throughout the duration of the conferences.
To schedule a meeting with Field Trip’s management team, please
contact KCSA Strategic Communications at fieldtripIR@kcsa.com.
About Field Trip Health Ltd.
Field Trip is a global leader in the development
and delivery of psychedelic therapies. With our Field Trip
Discovery division leading the development of the next generation
of psychedelic molecules and conducting advanced research on
plant-based psychedelics and our Field Trip Health division
building centres for psychedelic therapies opening across North
America and Europe along with the digital and technological tools
that will enable massive scale, we help people in need with a
simple, evidence-based way to heal and heighten engagement with the
world.
Learn more at https://www.meetfieldtrip.com,
https://www.fieldtriphealth.com and
https://www.fieldtriphealth.nl.
Follow us on Twitter and Instagram:
@fieldtriphealth.
To receive company updates about Field Trip and
to be added to the email distribution list please sign up here.
Cautionary Note Regarding
Forward-Looking Information
This release includes forward-looking
information (within the meaning of Canadian securities laws and
within the meaning of the United States Private Securities
Litigation Reform Act of 1995) regarding Field Trip and its
business. Often but not always, forward-looking information can be
identified by the use of words such as "expect", "intends",
"anticipated", "believes" or variations (including negative
variations) of such words and phrases, or state that certain
actions, events or results "may", "could", "would" or "will" be
taken, occur or be achieved. Such statements are based on the
current expectations and views of future events of the management
of Field Trip and are based on assumptions and subject to risks and
uncertainties. Although the management of Field Trip believes that
the assumptions underlying these statements are reasonable, they
may prove to be incorrect. The forward-looking events and
circumstances discussed in this release may not occur and could
differ materially as a result of known and unknown risk factors and
uncertainties affecting the companies, including those set forth in
the Company’s Annual Information Form and other market conditions,
economic factors, management's ability to manage and to operate the
business and the equity markets generally. Although Field Trip has
attempted to identify important factors that could cause actual
actions, events or results to differ materially from those
described in forward-looking statements, there may be other factors
that cause actions, events or results to differ from those
anticipated, estimated or intended. Accordingly, readers should not
place undue reliance on any forward-looking statements or
information. No forward-looking statement can be guaranteed. Except
as required by applicable securities laws, forward-looking
statements speak only as of the date on which they are made and
Field Trip does not undertake any obligation to publicly update or
revise any forward-looking statement, whether as a result of new
information, future events, or otherwise. Additional information
relating to Field Trip, including its Annual Information Form, can
be located on the SEDAR website at www.sedar.com and on the EDGAR
section of the SEC’s website at www.sec.gov.
This press release does not constitute an offer
to sell or the solicitation of an offer to buy securities.
Neither the Toronto Stock Exchange, nor its
Regulation Services Provider, have approved the contents of this
release or accept responsibility for the adequacy or accuracy of
this release.
CONTACTS:
Media contacts:Rachel MoskowitzAutumn
Communications202-276-7881press@fieldtriphealth.com
Nick Opich / McKenna MillerKCSA Strategic
Communications212-896-1206 /
347-487-6197press@fieldtriphealth.com
Investor contacts:Kathleen Heaney / Tim
ReganKCSA Strategic CommunicationsfieldtripIR@kcsa.com
SOURCE Field Trip Health Ltd.
Field Trip Health (TSX:FTRP)
Historical Stock Chart
From Jun 2024 to Jul 2024
Field Trip Health (TSX:FTRP)
Historical Stock Chart
From Jul 2023 to Jul 2024